Reported Side Effects
From 1,665 FDA adverse event reports (FAERS). 48.9% classified as serious.
| Side Effect | Reports |
|---|
DYSPNOEA | 271 |
DRUG INEFFECTIVE | 170 |
PNEUMONIA | 113 |
COUGH | 102 |
FATIGUE | 102 |
NAUSEA | 88 |
DEATH | 80 |
HEADACHE | 77 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 72 |
DIZZINESS | 71 |
DIARRHOEA | 68 |
OFF LABEL USE | 66 |
ASTHENIA | 63 |
PAIN | 63 |
MALAISE | 61 |
Data from FDA Adverse Event Reporting System (FAERS). Reports reflect consumer/provider submissions — higher counts may reflect higher usage, not necessarily higher risk. Not all reports establish a causal link.
Storage Information
HOW SUPPLIED Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg/3 mg per 3 mL is a clear, colorless solution. Practically free from visible particles and foreign matters packed in natural BFS LDPE vial and is supplied as a 3 mL sterile solution for nebulization in sterile low-density polyethylene unit-dose vials. Supplied in cartons as listed below. NDC 65862-906-30 30 x 3 mL unit dose vials per carton (6 pouches, each containing 5 vials per foil pouch) NDC 65862-906-60 60 x 3 mL unit dose vials per carton (12 pouches, each containing 5 vials per foil pouch) NDC 65862-906-03 30 x 3 mL unit dose vials per carton (30 pouches, each containing 1 vial per foil pouch) PROTECT FROM LIGHT. Unit dose vials should remain stored in the protective foil pouch at all times. Once removed from the foil pouch, the individual vials should be used within one week. Discard if the solution is not colorless. Store between 2º to 25ºC (36º to 77ºF). All brands listed are the trademarks of their respective owners and are not trademarks of Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg/3 mg per 3 mL Patient’s Instructions for Use Read this patient information completely every time your prescription is filled as information may have changed. Keep these instructions with your medication as you may want to read them again. Ipratropium bromide and albuterol sulfate inhalation solution should only be used under th
Important: This information is from federal drug label data and is for reference only. Always follow the specific expiration date printed on your medication packaging. Consult your pharmacist or healthcare provider with questions about medication storage or expiration.
Data source: View Ipratropium Bromide and Albuterol Sulfate on DailyMed (NIH) | Federal drug label data.
Page generated: 2026-03-29